Predicting drug-drug interactions between ayahuasca alkaloids and SSRIs using physiologically based pharmacokinetic modeling. [PDF]
Front Mol BiosciRibeiro GSG +13 more
europepmc +1 more source
Ayahuasca-assisted meaning reconstruction therapy as an early resource for bereavement: a non-randomized clinical trial. [PDF]
Sci RepSoto-Angona O +7 more
europepmc +1 more source
Extraction and Characterization of <i>N</i>,<i>N</i>‑Dimethyltryptamine from <i>Mimosa tenuiflora</i>: A Multivariate Approach. [PDF]
ACS Omegade Oliveira LC +10 more
europepmc +1 more source
Psychedelics and the Serotonin Hypothesis of Eating Disorders. [PDF]
Brain SciBilenker D, Avena NM.
europepmc +1 more source
Psychedelics for major depression-From controlled research settings into broader clinical use. [PDF]
Cell Rep MedAvram M, Borgwardt S.
europepmc +1 more source
Neurobiological research on N,N-dimethyltryptamine (DMT) and its potentiation by monoamine oxidase (MAO) inhibition: from ayahuasca to synthetic combinations of DMT and MAO inhibitors. [PDF]
Cell Mol Life SciEgger K +3 more
europepmc +1 more source
Cardiac effects of two hallucinogenic natural products, N,N-dimethyl-tryptamine and 5-methoxy-N,N-dimethyl-tryptamine. [PDF]
Sci RepNeumann J +4 more
europepmc +1 more source
Metabolic profiling reveals first evidence of fumigating drug plant Peganum harmala in Iron Age Arabia. [PDF]
Commun BiolHuber B +5 more
europepmc +1 more source
Untargeted metabolomics reveals quinic acid as the kiwifruit component that affects brain activity in mice. [PDF]
PLoS OneMarzo CM +7 more
europepmc +1 more source